138 related articles for article (PubMed ID: 6707946)
1. Presynaptic dopaminergic activity of phencyclidine in rat caudate.
Johnson SW; Haroldsen PE; Hoffer BJ; Freedman R
J Pharmacol Exp Ther; 1984 Apr; 229(1):321-32. PubMed ID: 6707946
[TBL] [Abstract][Full Text] [Related]
2. In vivo electrochemical demonstration of the presynaptic actions of phencyclidine in rat caudate nucleus.
Gerhardt GA; Pang K; Rose GM
J Pharmacol Exp Ther; 1987 May; 241(2):714-21. PubMed ID: 2883304
[TBL] [Abstract][Full Text] [Related]
3. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
Contreras PC; Johnson S; Freedman R; Hoffer B; Olsen K; Rafferty MF; Lessor RA; Rice KC; Jacobson AE; O'Donohue TL
J Pharmacol Exp Ther; 1986 Sep; 238(3):1101-7. PubMed ID: 3018219
[TBL] [Abstract][Full Text] [Related]
4. Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices.
Vickroy TW; Johnson KM
J Pharmacol Exp Ther; 1982 Dec; 223(3):669-74. PubMed ID: 6128403
[TBL] [Abstract][Full Text] [Related]
5. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo.
Snell LD; Mueller ZL; Gannon RL; Silverman PB; Johnson KM
J Pharmacol Exp Ther; 1984 Nov; 231(2):261-9. PubMed ID: 6092611
[TBL] [Abstract][Full Text] [Related]
6. [A study on the pharmacological action of phencyclidine].
Ohmori T
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):205-13. PubMed ID: 8099562
[TBL] [Abstract][Full Text] [Related]
7. Effects of dopamine on spontaneous and evoked activity of caudate neurons.
Johnson SW; Palmer MR; Freedman R
Neuropharmacology; 1983 Jul; 22(7):843-51. PubMed ID: 6621814
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological evidence for presynaptic actions of phencyclidine on noradrenergic transmission in rat cerebellum.
Marwaha J; Palmer MR; Woodward DJ; Hoffer BJ; Freedman R
J Pharmacol Exp Ther; 1980 Dec; 215(3):606-13. PubMed ID: 6255134
[TBL] [Abstract][Full Text] [Related]
9. Place-aversion conditioned by phencyclidine in rats: development of tolerance and pharmacologic antagonism.
Iwamoto ET
Alcohol Drug Res; 1985-1986; 6(4):265-76. PubMed ID: 2418852
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the failure of parenterally administered haloperidol to antagonize dopamine released from micropipettes in the caudate.
Johnson SW; Hoffer BJ; Freedman R
J Neurosci; 1986 Feb; 6(2):572-80. PubMed ID: 3081693
[TBL] [Abstract][Full Text] [Related]
11. Phencyclidine: behavioral and biochemical evidence supporting a role for dopamine.
Johnson KM
Fed Proc; 1983 Jun; 42(9):2579-83. PubMed ID: 6133782
[TBL] [Abstract][Full Text] [Related]
12. Presynaptic activation of the spinal serotonergic system in the rat by phencyclidine in vitro.
Ohno Y; Warnick JE
J Pharmacol Exp Ther; 1989 Jul; 250(1):177-83. PubMed ID: 2746496
[TBL] [Abstract][Full Text] [Related]
13. Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior.
Yamaguchi K; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 Dec; 9(12):975-86. PubMed ID: 3033192
[TBL] [Abstract][Full Text] [Related]
14. Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes.
Bowyer JF; Spuhler KP; Weiner N
J Pharmacol Exp Ther; 1984 Jun; 229(3):671-80. PubMed ID: 6726652
[TBL] [Abstract][Full Text] [Related]
15. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
Sershen H; Balla A; Aspromonte JM; Xie S; Cooper TB; Javitt DC
Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological effects of cyclazocine on rat cerebellar Purkinje neurons: comparison with phencyclidine.
Kim M; Pang K; Freedman R; Palmer M
Alcohol Drug Res; 1985-1986; 6(1):23-36. PubMed ID: 4074470
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
Umino A; Takahashi K; Nishikawa T
Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
[TBL] [Abstract][Full Text] [Related]
18. Effects of NMDA receptor inhibition by phencyclidine on the neuronal differentiation of PC12 cells.
Lee E; Williams Z; Goodman CB; Oriaku ET; Harris C; Thomas M; Soliman KF
Neurotoxicology; 2006 Jul; 27(4):558-66. PubMed ID: 16580729
[TBL] [Abstract][Full Text] [Related]
19. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist.
Bakshi VP; Geyer MA
J Pharmacol Exp Ther; 1997 Nov; 283(2):666-74. PubMed ID: 9353384
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of phencyclidine-induced dopamine-dependent behaviors in rats after pretreatments with serotonin-depletors.
Yamaguchi K; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 May; 9(5):479-89. PubMed ID: 2945001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
